Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Clinical trial NCT00698464 · COMPLETED

Trial details

NCT number: NCT00698464
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Cirrhosis Alcoholism

Start date: 2008-07-01
Primary completion: 2009-04-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.